EGFR
EGFR (epidermal growth factor receptor) inhibitors are compounds that block the signaling of EGFR, a receptor that is often overexpressed in various cancers and plays a critical role in angiogenesis. EGFR inhibitors are used to prevent tumor growth and metastasis by disrupting the pathways that promote blood vessel formation in tumors. These inhibitors are widely used in cancer research and therapy. At CymitQuimica, we offer a diverse selection of high-quality EGFR inhibitors to support your research in oncology and angiogenesis.
Read more
EGFR/CDK2-IN-3
EGFR/CDK2-IN-3 (compound 4b) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 …
Formula:
C30H20N6OS
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
512.58
Ref: TM-T79728
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
Intetumumab
CAS:725735-28-4
Intetumumab (CNTO 95) is a fully humanized anti-α(v)-integrin monoclonal antibody that is a radiosensitizer for …
Color and Shape:
Liquid
Molecular weight:
145.6 (kDa)
Ref: TM-T76812
| 1mg | 250.00 € | ||
| 5mg | 755.00 € | ||
| 10mg | 1,283.00 € | ||
| 25mg | 1,863.00 € | ||
| 50mg | 2,547.00 € | ||
| 100mg | 3,467.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Disitamab vedotin
CAS:2136633-23-1
Disitamab vedotin (RC-48) is a HER2-targeting ADC with MMAE, effective in HER2-expressing gastric cancer.
Purity:
95.00% - 98%
Color and Shape:
Liquid
Molecular weight:
Approximately 144.15 kDa
Ref: TM-T39595
| 1mg | 329.00 € | ||
| 5mg | 797.00 € | ||
| 10mg | 1,103.00 € | ||
| 25mg | 1,634.00 € | ||
| 50mg | 2,205.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Nezutatug
CAS:2673271-78-6
Nezutatug, an anti-HER3 antibody, serves as a research tool in cancer studies [1].
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T81679
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
Lumretuzumab
CAS:1448327-63-6
Lumretuzumab (RG-7116) is a humanized anti-HER3 monoclonal antibody with antitumor activity.
Color and Shape:
Liquid
Ref: TM-T76818
| 1mg | 264.00 € | ||
| 5mg | 660.00 € | ||
| 10mg | 1,035.00 € | ||
| 25mg | 1,568.00 € | ||
| 50mg | 2,110.00 € | ||
| 100mg | 2,783.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Barecetamab
CAS:2275727-74-5
Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity.
Color and Shape:
Liquid
Ref: TM-T76918
| 1mg | 311.00 € | ||
| 5mg | 1,008.00 € | ||
| 10mg | 1,359.00 € | ||
| 25mg | 2,015.00 € | ||
| 50mg | 2,717.00 € | ||
| 100mg | 3,668.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Cetuximab MMAE
Cetuximab-MMAE, an antibody-drug conjugate (ADC), combines an EGFR-targeting antibody with Monomethyl auristatin E (MMAE) to …
Color and Shape:
Liquid
Molecular weight:
150 kDa
Ref: TM-T9901A-219
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
DS06652923
DS06652923 is an orally active inhibitor targeting EGFR triple mutations. It exhibits growth-inhibitory effects on …
Color and Shape:
Odour Solid
Ref: TM-T200714
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
WAY-270360
CAS:476633-98-4
WAY-270360 (N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide) is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
Formula:
C22H19N3O3
Purity:
98.66%
Color and Shape:
Liquid
Molecular weight:
373.4
Ref: TM-T60064
| 1mg | 64.00 € | ||
| 5mg | 139.00 € | ||
| 10mg | 188.00 € | ||
| 25mg | 331.00 € | ||
| 50mg | 465.00 € | ||
| 100mg | 655.00 € | ||
| 500mg | 1,301.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Depatuxizumab MMAF
Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized …
Color and Shape:
Liquid
Molecular weight:
148.24 kDa
Ref: TM-T9901A-197
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
Losatuxizumab
CAS:1801544-27-3
Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody with potential anti-tumor activity for the study of …
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T77073
| 1mg | 203.00 € | ||
| 5mg | 523.00 € | ||
| 10mg | 838.00 € | ||
| 25mg | 1,245.00 € | ||
| 50mg | 1,617.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
JAK 3 inhibitor IV
CAS:58753-54-1
JAK 3 inhibitor IV (ZM 39923 hydrochloride) is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, …
Formula:
C16H19NO
Purity:
98%
Color and Shape:
Solid
Molecular weight:
241.33
Ref: TM-T2460
| 5mg | 67.00 € | ||
| 10mg | 107.00 € | ||
| 25mg | 190.00 € | ||
| 50mg | 316.00 € | ||
| 1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
EGFR-IN-76
CAS:2607829-38-7
EGFR-IN-76 is a potent EGFR inhibitor.
Formula:
C30H30ClFN6O2
Purity:
97.02% - 97.72%
Color and Shape:
Liquid
Molecular weight:
561.05
Ref: TM-T75120
| 1mg | 124.00 € | ||
| 5mg | 298.00 € | ||
| 10mg | 472.00 € | ||
| 25mg | 905.00 € | ||
| 50mg | 1,454.00 € | ||
| 100mg | 1,977.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
MTX-241F
MTX-241F, a selective small molecule inhibitor, targets members of the EGFR and PI3 kinase families.
Formula:
C20H14ClFN6
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
392.82
Ref: TM-T78877
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
1,5-Dihydroxyxanthone
CAS:14686-65-8
1,5-Dihydroxyxanthone inhibits EGFR-tyrosine kinase (IC50: 90.34 nM) and may block AChE/BChE.
Formula:
C13H8O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
228.203
Ref: TM-TN2504
| 5mg | 1,718.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
EGFR/BRAFV600E-IN-3
EGFR/BRAFV600E-IN-3 is an inhibitor targeting EGFR, BRAFV600E, and EGFRT790M with IC50 values of 57 nM, …
Formula:
C25H18N4O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
422.44
Ref: TM-T78850
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
SHR-A1201
SHR-A1201 is an antibody-drug conjugate (ADC) targeting HER2. This compound is composed of a humanized …
Formula:
C50H63ClF3N5O12
Color and Shape:
Liquid
Molecular weight:
1018.51
Ref: TM-T9901A-238
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
EGFR-IN-128
EGFR-IN-128 (compound 28) is a potent and selective molecule targeting wild-type EGFREx20Ins, demonstrating therapeutic efficacy …
Formula:
C27H20N4O
Color and Shape:
Liquid
Molecular weight:
416.47
Ref: TM-T201175
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
SOS1/EGFR-IN-2
SOS1/EGFR-IN-2 (Compound 4) functions as a dual inhibitor of SOS1 and EGFR, exhibiting IC50 values …
Formula:
C25H29F3N4O3
Color and Shape:
Liquid
Molecular weight:
490.52
Ref: TM-T200843
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
Trastuzumab rezetecan
CAS:2924909-11-3
Trastuzumab rezetecan (SHR-A1811) is an antibody-drug conjugate (ADC) targeting HER2. It is composed of a …
Color and Shape:
Liquid
Ref: TM-T9901A-231
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
